Oakland, California--(Newsfile Corp. - January 11, 2021) - The Magic Mushroom Company (OTCP Pink: MINE) specializing in growing, research, production and distribution of psilocybin mushrooms, announced today that Paul Hoonjan has been appointed as its new President.
KCSA Communications hosts an investment conference featuring Rick Doblin (MAPS) as a keynote speaker.
Tony White called his therapy session powered by magic mushrooms “a good trip.”
BetterLife Pharma Inc tapped the experience of psychedelic pioneer Hattie Wells to join its new psychedelic research advisory board.
The palm-fringed beachfront and breezy cabanas at MycoMeditations are the stuff of glossy travel brochures, but the barefoot vacationers roaming the Jamaican retreat center this winter are seeking a different kind of trip entirely.
Psychedelic Stock Watch connects the dots regarding Mind Cure's clinic launch and latest product development news.
Mind Cure's iSTRYM digital therapeutics platform is designed to provide real-time data regarding patient care.
While the world waited breathlessly this fall for anything resembling definitive results from the Nov. 3 presidential election, one early winner seemed clear: drugs.
Cybin Corp updates investors on its IP development
Numinus announces a product development agreement with Optimi Health Corp.
PALM BEACH, Fla., Jan. 6, 2021 /PRNewswire/ -- In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales.
During the November election, Oregon voters approved a measure allowing licensed centers to provide psilocybin, the substance found in “magic mushrooms,” to help treat people experiencing a range of mental health issues.
